Phase I Study of Immunotherapy of Hepatic Metastases of Colorectal Carcinoma by Direct Gene Transfer. Mayo Clinic, Rochester, Minnesota
- 1 November 1994
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 5 (11), 1385-1399
- https://doi.org/10.1089/hum.1994.5.11-1385
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- Recombinant Gene Expression in Vivo Within Endothelial Cells of the Arterial WallScience, 1989
- TUMOUR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN TREATMENT OF ADVANCED CANCERThe Lancet, 1989
- Immunotherapy of cancer using interleukin 2: current status and future prospectsImmunology Today, 1988
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Role of interleukin 2, interleukin 4, and alpha, beta, and gamma interferon in stimulating macrophage antibody-dependent tumoricidal activity.The Journal of Experimental Medicine, 1988
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Tumor Necrosis Factor (TNF)Science, 1985
- Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.The Journal of Experimental Medicine, 1985
- BCG lmmunotherapy of Malignant MelanomaAnnals of Surgery, 1974